Nationwide Children’s gene therapy spinoff acquired for $100M

Yet another gene therapy spinoff from Nationwide Children’s Hospital has been acquired for $100 million.

Celenex is developing a treatment for Batten Disease, a rare, fatal neurological condition that causes blindness and progressive loss of speech and movement. Children who inherit it typically don’t live past age 12.

Click here to read the complete article.

Story excerpt provided by Columbus Business First.

Written by Carrie Ghose.

Originally published September 21, 2018.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: